AstraZeneca
AZN
#53
Rank
A$405.60 B
Marketcap
A$261.54
Share price
0.19%
Change (1 day)
18.54%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): A$10.53

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is A$9.70. In 2024 the company made an earnings per share (EPS) of A$6.34 an increase over its 2023 EPS that were of A$5.36.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)A$10.53
2024A$6.3418.23%
2023A$5.3681.13%
2022A$2.96631.03%
2021A$0.40-88.11%
2020A$3.41136.89%
2019A$1.44-39.41%
2018A$2.37-28.27%
2017A$3.31-14.37%
2016A$3.8624.11%
2015A$3.11127.55%
2014A$1.37-51.96%
2013A$2.85-58.95%
2012A$6.94-32.2%
2011A$10.23

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
A$12.19 25.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
A$9.80 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
A$1.83-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
A$5.04-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$39.39 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$3.57-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
A$13.05 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
A$4.96-48.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
A$4.97-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
A$5.42-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK